跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,586 条关于
“Eikonoklastes Therapeutics LLC”
全部
19,586
临床试验
4,089
药物
3,539
机构
2,750
资讯
9,208
3个月前
Systemic Gene Therapy SynCav1 Shields Brain from TDP-43 Damage by Fortifying Neuronal Resilience
去年
Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
7年前
FDA Rejects Mallinckrodt's Abuse-Deterrent Roxicodone Reformulation
去年
Relief Therapeutics Receives $2 Million Milestone Payment After FDA Approval of Arimoclomol
去年
Qualigen Therapeutics Secures $4.5 Million in Series A-3 Preferred Stock Financing to Advance Cancer Therapeutics Pipeline
去年
Rosacea Therapeutics: Emerging Therapies and Market Outlook
去年
TBI Therapeutics Advance Through Clinical Trials: SanBio's SB623 Receives Sakigake Designation
2年前
Qualigen Therapeutics Announces Public Offering to Advance Cancer Programs
去年
Context Therapeutics Acquires Rights to BioAtla's Nectin-4 x CD3 TCE, BA3362, for up to $133 Million
第 1 页，共 921 页
上一页
下一页
